Laboratory diagnosis of the lupus anticoagulant

Current Rheumatology Reports

Volumn 14, Issue 1, 2012, Pages 64-70

  Ortel, Thomas L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiphospholipid antibody; Antiphospholipid syndrome; Coagulation; Diagnosis; Hypercoagulable state; Laboratory; Lupus anticoagulant; Thromboembolism; Thrombosis

Indexed keywords

ANTIVITAMIN K; ARGATROBAN; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DABIGATRAN ETEXILATE; DALTEPARIN; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; RIVAROXABAN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; HEMOSTASIS; HUMAN; LABORATORY DIAGNOSIS; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; STROKE; THROMBOCYTOPENIA; THROMBOSIS;

BLOOD COAGULATION TESTS; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOEMBOLISM;

EID: 84857048723     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0225-3     Document Type: Review

References (40)

1. CL Conley RC Hartmann 1952 A Hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus J Clin Invest. 31 621 2
2. SL Lee M Sanders 1955 A disorder of blood coagulation in systemic lupus erythematosus J Clin Invest. 34 12 1814 22 13271567 10.1172/JCI103237 1:CAS:528:DyaG28XitFWgtw%3D%3D
3. EJ Bowie JH Thompson Jr CA Pascuzzi CA Owen Jr 1963 Thrombosis in systemic lupus erythematosus despite circulating anticoagulants J Lab Clin Med. 62 416 30 14061973 1:STN:280:DyaF2c%2FhvFKjsg%3D%3D
4. JR Mueh KD Herbst SI Rapaport 1980 Thrombosis in patients with the lupus anticoagulant Ann Intern Med. 92 2 Pt 1 156 9 7352719 1:STN:280: DyaL3c7gslKqsw%3D%3D (Pubitemid 10141570)
5. ML Boey CB Colaco AE Gharavi KB Elkon S Loizou GR Hughes 1983 Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant Br Med J (Clin Res Ed). 287 6398 1021 3 10.1136/bmj.287.6398.1021 1:STN:280:DyaL2c%2FgtFajsw%3D%3D (Pubitemid 13009248)
6. DI Feinstein SI Rapaport 1972 Acquired inhibitors of blood coagulation Prog Hemost Thromb. 1 75 95 4569725 1:CAS:528:DyaE3sXhsFOnsbo%3D
7. MA Schleider RL Nachman EA Jaffe M Coleman 1976 A clinical study of the lupus anticoagulant Blood. 48 4 499 509 963290 1:CAS:528:DyaE28XlvFSgtLw%3D
8. RR Proctor SI Rapaport 1961 The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies Am J Clin Pathol. 36 212 9 13738153 1:STN:280:DyaF3c%2Flslyhsw%3D%3D
9. SI Rapaport SB Ames BJ Duvall 1960 A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity Blood. 15 212 27 14436248 1:STN:280: DyaF3c7ovV2rsg%3D%3D
10. A Margolius Jr DP Jackson OD Ratnoff 1961 Circulating anticoagulants: a study of 40 cases and a review of the literature Medicine (Baltimore). 40 145 202
11. PM Mannucci MT Canciani D Mari P Meucci 1979 The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant Scand J Haematol. 22 5 423 32 472662 10.1111/j.1600-0609.1979.tb00440.x 1:STN:280:DyaE1M3kvVKiuw%3D%3D (Pubitemid 9232588)
12. DM Adcock RA Marlar 1992 Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant Arch Pathol Lab Med. 116 8 837 40 1497465 1:STN:280:DyaK38zlvFKrtg%3D%3D
13. T Exner DA Triplett D Taberner SJ Machin 1991 Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants Thromb Haemost 65 3 320 2 1904657 1:STN:280:DyaK3M3mt12qsg%3D%3D
14. LAW Party 1991 Guidelines on testing for the lupus anticoagulant J Clin Pathol. 44 885 9 10.1136/jcp.44.11.885
15. JT Brandt DA Triplett B Alving I Scharrer 1995 Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thromb Haemost. 74 4 1185 90 8560433 1:CAS:528: DyaK2MXptVyhs7Y%3D
16. V Pengo A Tripodi G Reber JH Rand TL Ortel M Galli, et al. 2009 Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis J Thromb Haemost. 7 10 1737 40 19624461 10.1111/j.1538-7836.2009.03555.x 1:CAS:528:DC%2BD1MXhtlGnsb%2FE
17. M Galli G Finazzi EM Bevers T Barbui 1995 Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies Blood. 86 2 617 23 7605991 1:CAS:528:DyaK2MXmvVyhur8%3D
18. A Tripodi A Biasiolo V Chantarangkul V Pengo 2003 Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity Clin Chem. 49 10 1608 14 14500585 10.1373/49.10.1608 1:CAS:528:DC%2BD3sXnvVyht78%3D (Pubitemid 37194214)
19. J Arnout P Meijer J Vermylen 1999 Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I Thromb Haemost. 81 6 929 34 10404770 1:CAS:528: DyaK1MXjvFahtrc%3D (Pubitemid 29312710)
20. KA Moffat MR Ledford-Kraemer EA Plumhoff H McKay WL Nichols P Meijer, et al. 2009 Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices Thromb Haemost. 101 1 178 84 19132206 1:CAS:528:DC%2BD1MXhvVWrurs%3D
21. I Jennings S Kitchen DP Kitchen TA Woods ID Walker 2011 ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories? J Thromb Haemost. 9 10 2117 9 21794074 10.1111/j.1538-7836.2011. 04448.x 1:STN:280:DC%2BC3MfntlajsQ%3D%3D
22. I Jennings S Kitchen TA Woods FE Preston M Greaves 1997 Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation Thromb Haemost. 77 5 934 7 9184405 1:CAS:528:DyaK2sXjsFSrtLk%3D (Pubitemid 27239117)
23. J Teruya AG West MN Suell 2007 Lupus anticoagulant assays: questions answered and to be answered Arch Pathol Lab Med. 131 6 885 9 17550315 (Pubitemid 46906379)
24. BK Ip AR Thomson HT Moriarty 2001 A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin Pathology. 33 3 347 52 11523938 1:CAS:528:DC%2BD3MXms1Wjtbg%3D (Pubitemid 32735251)
25. S Liestol F Wisloff 2005 Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays Thromb Res. 115 6 509 17 15792683 10.1016/j.thromres.2004.11.013 1:CAS:528:DC%2BD2MXisFGksr0%3D (Pubitemid 40409985)
26. LA Linkins JA Julian J Rischke J Hirsh JI Weitz 2002 In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation Thromb Res. 107 5 241 4 12479885 10.1016/S0049-3848(02)00340-7 1:CAS:528:DC%2BD38XptlCrtrs%3D (Pubitemid 35435383)
27. RC Gosselin JH King KA Janatpur WH Dager EC Larkin JT Owings 2004 Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing Arch Pathol Lab Med. 128 10 1142 5 15387708 1:CAS:528: DC%2BD2cXptVOms7w%3D (Pubitemid 39313368)
28. A Tripodi V Chantarangkul M Clerici PM Mannucci 2002 Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thromb Haemost. 88 4 583 6 12362227 1:CAS:528:DC%2BD38XosVars7k%3D (Pubitemid 35173998)
29. H Olteanu KA Downes J Patel D Praprotnik R Sarode 2009 Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time Clin Lab. 55 3-4 138 42 19462936
30. JR Genzen JL Miller 2005 Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing Am J Clin Pathol. 124 4 586 93 16146819 10.1309/7RYUN5DRK4WCH3PM 1:CAS:528: DC%2BD2MXhtFChsbbF (Pubitemid 41395640)
31. D Garcia E Libby MA Crowther 2010 The new oral anticoagulants Blood. 115 1 15 20 19880491 10.1182/blood-2009-09-241851 1:CAS:528:DC%2BC3cXnvVOqtQ%3D%3D
32. A Hillarp F Baghaei I Fagerberg Blixter KM Gustafsson L Stigendal M Sten-Linder, et al. 2011 Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays J Thromb Haemost. 9 1 133 9 20946166 10.1111/j.1538-7836.2010.04098.x 1:CAS:528:DC%2BC3MXitFCqtrs%3D
33. E Merriman Z Kaplan J Butler E Malan E Gan H Tran 2011 Rivaroxaban and false positive lupus anticoagulant testing Thromb Haemost. 105 2 385 6 21103666 10.1160/TH10-08-0511 1:CAS:528:DC%2BC3MXislahsLw%3D
34. GM van Os B de Laat PW Kamphuisen JC Meijers PG de Groot 2011 Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time J Thromb Haemost. 9 8 1657 9 21668740 10.1111/j.1538-7836.2011.04395.x
35. YC Barrett Z Wang C Frost A Shenker 2010 Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay Thromb Haemost. 104 6 1263 71 20978714 10.1160/TH10-05-0328 1:CAS:528:DC%2BC3MXht1aksLs%3D
36. V Baca G Montiel L Meillon J Pizzuto T Catalan L Juan-Shum, et al. 2002 Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature Am J Hematol. 71 3 200 7 12410576 10.1002/ajh.10194 (Pubitemid 35253336)
37. R Bortoli OA Monticielo RM Chakr PE Palominos LM Rohsig CL Kohem, et al. 2009 Acquired factor XI inhibitor in systemic lupus erythematosus-case report and literature review Semin Arthritis Rheum. 39 1 61 5 18519152 10.1016/j.semarthrit.2008.03.005 1:CAS:528:DC%2BD1MXptVSht7g%3D
38. A Taher R Abiad I Uthman 2003 Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance Lupus. 12 11 854 6 14667103 10.1191/0961203303lu463cr 1:STN:280:DC%2BD3srosFGgtw%3D%3D (Pubitemid 37463104)
39. S Miyakis MD Lockshin T Atsumi DW Branch RL Brey R Cervera, et al. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost. 4 2 295 306 16420554 10.1111/j.1538-7836.2006.01753.x 1:CAS:528:DC%2BD28XisVSjuro%3D
40. V Pengo A Ruffatti C Legnani S Testa T Fierro F Marongiu, et al. 2011 Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study Blood. 118 17 4714 8 21765019 10.1182/blood-2011-03-340232 1:CAS:528:DC%2BC3MXhsVGqu7fL